185 related articles for article (PubMed ID: 34688299)
1. Development of therapies for rare genetic disorders of GPX4: roadmap and opportunities.
Cheff DM; Muotri AR; Stockwell BR; Schmidt EE; Ran Q; Kartha RV; Johnson SC; Mittal P; Arnér ESJ; Wigby KM; Hall MD; Ramesh SK
Orphanet J Rare Dis; 2021 Oct; 16(1):446. PubMed ID: 34688299
[TBL] [Abstract][Full Text] [Related]
2. Mutations in the enzyme glutathione peroxidase 4 cause Sedaghatian-type spondylometaphyseal dysplasia.
Smith AC; Mears AJ; Bunker R; Ahmed A; MacKenzie M; Schwartzentruber JA; Beaulieu CL; Ferretti E; ; Majewski J; Bulman DE; Celik FC; Boycott KM; Graham GE
J Med Genet; 2014 Jul; 51(7):470-4. PubMed ID: 24706940
[TBL] [Abstract][Full Text] [Related]
3. Sedaghatian-type spondylometaphyseal dysplasia: Whole exome sequencing in neonatal dry blood spots enabled identification of a novel variant in GPX4.
Fedida A; Ben Harouch S; Kalfon L; Abunassar Z; Omari H; Mandel H; Falik-Zaccai TC
Eur J Med Genet; 2020 Nov; 63(11):104020. PubMed ID: 32827718
[TBL] [Abstract][Full Text] [Related]
4. Sedaghatian spondylometaphyseal dysplasia in two siblings.
Peshimam N; Farah H; Caswell R; Ellard S; Jan W; Calder AD; Cobben J; Kariholu U; Leitch HG
Eur J Med Genet; 2022 Aug; 65(8):104541. PubMed ID: 35718083
[TBL] [Abstract][Full Text] [Related]
5. Simplified gyral pattern with cerebellar hypoplasia in Sedaghatian type spondylometaphyseal dysplasia: a clinical report and review of the literature.
Aygun C; Celik FC; Nural MS; Azak E; Kucukoduk S; Ogur G; Incesu L
Am J Med Genet A; 2012 Jun; 158A(6):1400-5. PubMed ID: 22529034
[TBL] [Abstract][Full Text] [Related]
6. Cardiolipin drives the catalytic activity of GPX4 on membranes: Insights from the R152H mutant.
Roveri A; Di Giacinto F; Rossetto M; Cozza G; Cheng Q; Miotto G; Zennaro L; Di Paolo ML; Arnér ESJ; De Spirito M; Maiorino M; Ursini F
Redox Biol; 2023 Aug; 64():102806. PubMed ID: 37413766
[TBL] [Abstract][Full Text] [Related]
7. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
8. Spondylometaphyseal dysplasia Sedaghatian type associated with lethal arrhythmia and normal intrauterine growth in three siblings.
Kerr B; Smith V; Patel R; Ladusans E; Sillence DO
Clin Dysmorphol; 2000 Jul; 9(3):167-72. PubMed ID: 10955475
[TBL] [Abstract][Full Text] [Related]
9. A female case of Sedaghatian type spondylometaphyseal dysplasia.
Foulds N; Fairhurst J; Temple IK; Cade S; Groves C; Lancaster T
Am J Med Genet A; 2003 May; 118A(4):377-81. PubMed ID: 12687672
[TBL] [Abstract][Full Text] [Related]
10. Sedaghatian spondylometaphyseal dysplasia with pachygyria and absence of the corpus callosum.
English SJ; Gayatri N; Arthur R; Crow YJ
Am J Med Genet A; 2006 Sep; 140A(17):1854-8. PubMed ID: 16892303
[TBL] [Abstract][Full Text] [Related]
11. Spondylometaphyseal dysplasia-Sedaghatian type.
Elçioglu N; Hall CM
Am J Med Genet; 1998 Apr; 76(5):410-4. PubMed ID: 9556300
[TBL] [Abstract][Full Text] [Related]
12. Spondylometaphyseal dysplasia: Sedaghatian type.
Koutouby A; Habibullah J; Moinuddin FA
Am J Med Genet; 2000 Jan; 90(3):199-202. PubMed ID: 10678656
[TBL] [Abstract][Full Text] [Related]
13. Deciphering potential pharmacological mechanism of Sha-Shen-Mai-Dong decoction on primary Sjogren's syndrome.
Jiang Y; Zhao X; Yu J; Wang Q; Wen C; Huang L
BMC Complement Med Ther; 2021 Mar; 21(1):79. PubMed ID: 33648502
[TBL] [Abstract][Full Text] [Related]
14. Towards efficiency in rare disease research: what is distinctive and important?
Jia J; Shi T
Sci China Life Sci; 2017 Jul; 60(7):686-691. PubMed ID: 28639105
[TBL] [Abstract][Full Text] [Related]
15. Osteochondral diseases and fibrodysplasia ossificans progressiva.
Morales-Piga A; Kaplan FS
Adv Exp Med Biol; 2010; 686():335-48. PubMed ID: 20824454
[TBL] [Abstract][Full Text] [Related]
16. Delineating the role of glutathione peroxidase 4 in protecting cells against lipid hydroperoxide damage and in Alzheimer's disease.
Yoo MH; Gu X; Xu XM; Kim JY; Carlson BA; Patterson AD; Cai H; Gladyshev VN; Hatfield DL
Antioxid Redox Signal; 2010 Apr; 12(7):819-27. PubMed ID: 19769463
[TBL] [Abstract][Full Text] [Related]
17. Molecular, phenotypic aspects and therapeutic horizons of rare genetic bone disorders.
Faruqi T; Dhawan N; Bahl J; Gupta V; Vohra S; Tu K; Abdelmagid SM
Biomed Res Int; 2014; 2014():670842. PubMed ID: 25530967
[TBL] [Abstract][Full Text] [Related]
18. Spondylometaphyseal dysplasia, Sedaghatian type.
Peeden JN; Rimoin DL; Lachman RS; Dyer ML; Gerard D; Gruber HE
Am J Med Genet; 1992 Nov; 44(5):651-6. PubMed ID: 1481828
[TBL] [Abstract][Full Text] [Related]
19. Sedaghatian congenital lethal metaphyseal chondrodysplasia--observations in a second Iranian family and histopathological studies.
Opitz JM; Spranger JW; Stöss HR; Pesch HJ; Azadeh B
Am J Med Genet; 1987 Mar; 26(3):583-90. PubMed ID: 3565474
[TBL] [Abstract][Full Text] [Related]
20. Spondylometaphyseal dysplasia-Sedaghatian type associated with intra-partum cardiac arrhythmia and neonatal death.
Mahendran SM; Wilcox FL; Chirumamila L
J Obstet Gynaecol; 2007 Nov; 27(8):851-3. PubMed ID: 18097914
[No Abstract] [Full Text] [Related]
[Next] [New Search]
